About Errik Anderson
Form D filings for Aakha Biologics in 2024 list Errik Anderson as director.
Form D filings also name Errik Anderson as a founder, CEO, chairman of alloy at Alloy Therapeutics and a director at Angiex.
Errik Anderson reports to the SEC as a major shareholder of 1 public company: Compass Therapeutics (CMPX).
Errik Anderson first appears on SEC filings in 2020.
Experience
This experience comes from Errik Anderson's profile and from SEC filings. For roles taken from filings, the years are when the filings name Errik Anderson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Errik Anderson works with at each company, as listed on that company's latest Form D.

